April 27th, 2012 by Eboni Morris
...
(Keep Reading)
April 27th, 2012 by Katie Whittle
Link to Access HCV Therapy Site
Friends and supporters,
We should all be enormously encouraged by the increasing cascade of promising results from investigational HCV drug trials. A couple of years ago, greatly improved therapy was a dream. Now, some investigational drug ...
(Keep Reading)
March 16th, 2012 by Eboni Morris
By Jane Norman, CQ HealthBeat Associate Editor
The Department of Health and Human Services wants input on how to design a study that would detail under what circumstances men who have a history of sex with other men should be allowed ...
(Keep Reading)
October 28th, 2011 by Eboni Morris
By Anna Edney
Courtesy of Bloomberg News
Oct. 26 (Bloomberg) -- Two Chinese companies implicated in supplying contaminated ingredients three years ago to Baxter International Inc. for its blood thinner heparin are still supplying product to the U.S., Republican lawmakers said.
Baxter recalled ...
(Keep Reading)
September 5th, 2011 by Eboni Morris
CQ TODAY ONLINE NEWS – HEALTH
Sept. 2, 2011 – 8:17 p.m.
By Emily Ethridge, CQ Staff
The pharmaceutical industry continues to push lawmakers to act quickly on approving a deal that would fund the Food and Drug Administration’s drug review process.
But, although ...
(Keep Reading)
September 2nd, 2011 by Eboni Morris
By instilling confidence in U.S. products and technologies, we stimulate economic growth and open markets overseas.
By MARGARET A. HAMBURG
Courtesy of the Wall Street Journal
There are encouraging signs that the pharmaceutical industry's pipeline of new products is not as stalled as some ...
(Keep Reading)
May 16th, 2011 by Katie Whittle
Click here for New York Times article.
By ANDREW POLLACK
Published: May 13, 2011
The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time ...
(Keep Reading)
April 9th, 2010 by kcarter
For the past few weeks, media attention, US Senate interest and federal agency meetings scheduled on the topic of blood safety and donor deferral criteria have been circulating. Specifically, Senator John Kerry (D-MA) sent a letter to the FDA Commissioner, ...
(Keep Reading)
January 18th, 2010 by kcarter
Questions like “What is the approval process for a biological product and what does the FDA do?” are answered on the Food and Drug Administration’s (FDA) new “FDA Basics” web page. The FDA created a new web page to assist ...
(Keep Reading)
